Enanta Pharmaceuticals Inc (ENTA)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Enanta Pharmaceuticals Inc (ENTA) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2025-12-31	2025-03-31	2024-12-31	2024-06-30	2024-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	24.72% 18.61	14.93	16.96	17.97	17.05
Operating Expenses	24.29% 29.87	39.45	40.50	42.16	49.82
Benefits Costs and Expenses	21.47% 30.53	38.88	39.66	41.02	48.57
Costs And Expenses	24.29% 29.87	39.45	40.50	42.16	49.82
Depreciation and Amortization	2.24% 1.23	1.203	0.889	0.594	0.621
Operating Income/Loss	54.12% -11.25	-24.53	-23.54	-24.18	-32.77
Nonoperating Income/Loss	214.36% -0.661	0.578	0.837	1.132	1.246
Income/Loss From Continuing Operations Before Tax	50.25% -11.91	-23.95	-22.71	-23.05	-31.52
Income Tax Expense/Benefit	101.84% 0.024	-1.305	-0.416	-0.395	-0.363
Income/Loss From Continuing Operations After Tax	47.28% -11.94	-22.64	-22.29	-22.66	-31.16
Net Income/Loss	47.28% -11.94	-22.64	-22.29	-22.66	-31.16
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	34.62% 28.75	21.36	21.24	21.18	21.17
Diluted Average Shares	34.62% 28.75	21.36	21.24	21.18	21.17
Basic Earnings Per Share	60.38% -0.42	-1.06	-1.05	-1.07	-1.47
Diluted Earnings Per Share	60.38% -0.42	-1.06	-1.05	-1.07	-1.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$27.36

1.82%

RPRX

$47.03

3.20%

MRNA

$53.54

4.29%

BNTX

$88.77

2.26%

ONC

$283.45

2.81%

INSM

$148.31

6.59%